<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    PTC Therapeutics, Inc.

    PTC Therapeutics, Inc.

    PTC is a science-led, global biopharmaceutical company focused on the discovery, d...

    PTC is a science-led, global biopharmaceutical ...

    Filing Type:    PU
    Apollo Endosurgery, Inc.

    Apollo Endosurgery, Inc.

    Apollo Endosurgery, Inc. is a medical device company focused on less invasive ther...

    Apollo Endosurgery, Inc. is a medical device co...

    Filing Type:    PU
    Kindred Biosciences, Inc.

    Kindred Biosciences, Inc.

    KindredBio is focused on bringing breakthrough human products and innovative new t...

    KindredBio is focused on bringing breakthrough ...

    Filing Type:    PU
    Sesen Bio, Inc.

    Sesen Bio, Inc.

    At Sesen Bio, we are committed to renewing life for people with cancer. We are a l...

    At Sesen Bio, we are committed to renewing life...

    Filing Type:    PU
    Translate Bio, Inc.

    Translate Bio, Inc.

    Translate Bio is a leading mRNA therapeutics company developing a new class of pot...

    Translate Bio is a leading mRNA therapeutics co...

    Filing Type:    PU
    Cassava Sciences, Inc.

    Cassava Sciences, Inc.

    The mission of Cassava Sciences is to detect and treat neurodegenerative diseases,...

    The mission of Cassava Sciences is to detect an...

    Filing Type:    PU
    bluebird bio, Inc.

    bluebird bio, Inc.

    bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., h...

    bluebird bio is pioneering gene therapy with pu...

    Filing Type:    PU
    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-base...

    Takeda Pharmaceutical Company Limited (TSE:4502...

    Filing Type:    PU
    Nymox Pharmaceutical Corporation

    Nymox Pharmaceutical Corporation

    Nymox Pharmaceutical Corporation specializes in the research and development of th...

    Nymox Pharmaceutical Corporation specializes in...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.